source
- Celcuity’s breast cancer therapy gets FDA approval as new CBER chief outlines biotech prioritiesCelcuity announced that its first breast cancer drug has been approved by the U.S. Food and Drug Administration, marking the company’s initial market entry in oncology. The announcement coincided…
- J&J restructures pharma supply chain, offloading sites as part of $55 B U.S. manufacturing pushJohnson & Johnson announced it is restructuring its pharmaceutical supply chain, offloading certain sites to streamline operations as part of its $55 billion U.S. manufacturing initiative. The cha…